MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$3,384K
Net Income
$24,648K
Net Profit Margin
728.37%
EPS
-$0.44
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2024-09-30
Collaboration revenue
3,384
3,227
9,027
Cost of revenue
-
-
4,725
Gross profit
-
-
4,302
Research and development
25,280
20,036
2,694
General and administrative
7,003
5,897
6,944
Total operating expenses
32,283
25,933
9,638
Loss from operations
-28,899
-22,706
-5,336
Interest income
4,765
4,384
-
Other expense, net
-10
-3
-4
Gain (loss) from litigation settlement
-
-
-366
Interest income (expense), operating
-
-
-713
Total other income, net
4,755
4,381
-1,083
Income (loss) from continuing operations before income taxes, noncontrolling interest
-
-
-6,419
Income tax expense (benefit)
-
-
1
Net loss
-24,144
-18,325
-6,420
Net unrealized loss on marketable securities
-504
-283
-
Comprehensive loss
24,648
18,608
-
Basic EPS
-0.44
-0.38
-0.04
Diluted EPS
-0.44
-0.38
-0.04
Basic Average Shares
55,300,107
48,630,038
154,426,333
Diluted Average Shares
55,300,107
48,630,038
154,426,333
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Research and development
$25,280K
General and
administrative
$7,003K
Total operating
expenses
$32,283K
Loss from operations
-$28,899K
Collaboration revenue
$3,384K
Net loss
-$24,144K
Net unrealized loss
on marketable...
-$504K
Total other income,
net
$4,755K
Other expense, net
-$10K
Comprehensive loss
$24,648K
Interest income
$4,765K
Buy us a coffee
Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS)